|
Total LSCD
|
|---|
|
No.
|
AGE
|
SEX
|
LSCD etiology
|
Type
|
Follow-up (months)
|
VA before
|
VA after
|
Tx Post LEC TX
|
Result
|
|---|
|
1
|
44
|
M
|
Chemical burn
|
allo* auto
|
41
|
CF (0.014)
|
CF (0.014)
|
PK
|
Failed
|
|
2
|
45
|
F
|
Chemical burn
|
auto
|
43
|
HM (0.005)
|
0,05
|
-
|
AS, FS
|
|
4
|
45
|
M
|
Chemical burn
|
auto
|
31
|
CF (0.014)
|
<0,05
|
-
|
Failed
|
|
5
|
6
|
M
|
Chemical burn
|
auto
|
31
|
HM (0.005)
|
LP (0)
|
PK
|
Failed
|
|
6
|
27
|
M
|
Aniridia
|
allo**
|
27
|
0.053
|
0.1
|
PK
|
AS, FS
|
|
7
|
70
|
F
|
Corneal ulcer
|
auto
|
25
|
LP (0)
|
HM (0.005)
|
PK
|
AS, FS
|
|
8
|
29
|
M
|
Chemical burn
|
auto
|
25
|
<0,05
|
HM (0.005)
|
-
|
Failed
|
|
10
|
33
|
M
|
Chemical burn
|
auto
|
19
|
LP (0)
|
LP (0)
|
-
|
Failed
|
|
11
|
63
|
M
|
Iatrogenic
|
auto
|
19
|
HM (0.005)
|
HM (0.005)
|
-
|
AS
|
|
13
|
31
|
F
|
Aniridia
|
allo**
|
48
|
CF (0.014)
|
0.2
|
PK
|
AS, FS
|
|
14
|
16
|
F
|
Kniest syndrome
|
auto
|
6
|
LP (0)
|
HM (0.005)
|
-
|
AS
|
|
15
|
6
|
M
|
Keratitis
|
auto
|
5
|
LP (0)
|
LP (0)
|
-
|
Failed
|
|
16
|
48
|
M
|
Chemical burn
|
auto
|
4
|
CF (0.014)
|
0.125
|
-
|
AS, FS
|
|
17
|
79
|
M
|
Trauma
|
auto
|
4
|
CF (0.014)
|
CF (0.014)
|
-
|
AS
|
|
18
|
42
|
F
|
Viral keratitis
|
auto
|
18
|
LP (0)
|
HM (0.005)
|
PK
|
AS, FS
|
|
Partial LSCD
|
|
No.
|
AGE
|
SEX
|
LSCD Etiology
|
Type
|
Follow-up (months)
|
VA before
|
VA after
|
Tx Post LEC TX
|
Result
|
|
3
|
57
|
F
|
Iatrogenic
|
auto
|
39
|
0.15
|
0,16
|
-
|
AS, FS
|
|
9
|
44
|
F
|
Keratitis, uveitis
|
auto
|
24
|
CF (0.014)
|
0.15
|
PK
|
AS, FS
|
|
12
|
47
|
M
|
Trauma
|
auto
|
18
|
0.2
|
0.9
|
-
|
AS, FS
|
- The table shows the subject code, age, sex, etiology of LCSD (Limbal Stem Cell Deficency), type of donor (allo* = allogenic cadaveric, allo** = from living related donor), the follow-up, visual acuities pre and post op (LP = light perception, CF = counting fingers, HM = hand movements) surgical interventions following LEC TX (Limbal epithelial cell transplant) particularly PK (penetrating keratoplasty) procedures and the vision at most recent follow-up (AS = anatomical success, FS = functional success).
